NeoGenomics, Inc. (NEO) Revenue History
NeoGenomics, Inc. (NEO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $244.08M |
| 2017-12-31 | $258.61M |
| 2018-12-31 | $276.74M |
| 2019-12-31 | $408.83M |
| 2020-12-31 | $444.45M |
| 2021-12-31 | $484.33M |
| 2022-12-31 | $509.73M |
| 2023-12-31 | $591.64M |
| 2024-12-31 | $660.57M |
| 2025-12-31 | $727.33M |
How NEO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| USPH | U.S. Physical Therapy Inc. | $780.99M |
| EBS | Emergent BioSolutions Inc. | $742.90M |
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| AXSM | Axsome Therapeutics Inc. | $638.50M |
These are five companies in the same sector as NEO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get NeoGenomics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("NEO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NEO | $16.98 | +2.72% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 |